Home
About Us
Investors
TRC Technology
Clinical Programs
News
Careers
Contact
Corporate Overview
Aastrom Advantages
Management Team & Directors
Financial Information
Stock Information
Shareholder Services
Corporate Governance
Cell Manufacturing
Understanding Stem Cells
Intellectual Property
Cardiac Regeneration
Vascular Regeneration
Bone Regeneration
Publications
Press Releases
Aastrom in the News
Register for Email
Calendar of Events
Print page
|
Email page
Financial Information
Quarterly Results
Annual Reports/Proxy
SEC Filings
Financial News
Stock Information
Stock Performance
Historic Stock Lookup
Investment Calculator
Analyst Coverage
Shareholder Services
Investor FAQs
Shareholder Electronic Delivery
Contact Us
Corporate Governance
Board of Directors
Committees & Charters
Insider Transactions
Insider Ownership
Investor Relations
Essential Governance Documents
Document
View
Charter of the Audit Committee of the Board of Directors
16.7 KB
Charter for the Compensation Committee of the Board of Directors
9.7 KB
Charter of the Governance and Nominating Committee of the Board of Directors
16.7 KB
Code of Business Conduct and Ethics
35.4 KB
Board Member Attendance at Annual Meetings Policy
5.4 KB
Director Nominations Policy
9.3 KB
Code of Ethics for Senior Financial Officers
6.0 KB
Shareholder Communications with Directors Policy
6.0 KB
Stock Information
ASTMD - (NASDAQ)
$1.50
- 0.03
03-10-10
3:59 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Shareholder Tools
Investor Briefcase
Investor Kit
News/Event Alerts
Download Library
News Feeds
Home
|
Forward Looking Statement
Aastrom Biosciences, Inc. · Tel: 734-930-5555 © 2010